Chronic Obstructive Pulmonary Disease Market to Witness Upsurge in Growth During the Forecast Period (2023–2032), Assesses DelveInsight | Key Companies - Genentech, GlaxoSmithKline, Regeneron, Sanofi, AstraZeneca, Mereo, Inmunotek New York, USA, Sept. 25, 2023 (GLOBE NEWSWIRE) -- Chronic Obstructive Pulmonary Disease Market to Witness Upsurge in Growth During the Forecast Period (2023–2032), Assesses DelveInsight | Key...

DirectRx Takes the Lead in Lung Health for Patients Nationwide TROY, Mich., June 07, 2023 (GLOBE NEWSWIRE) -- DirectRx, a leading national specialty pharmacy dedicated to serving individual patients with complex and chronic health needs, has launched a new...

Chronic Obstructive Pulmonary Disease Clinical Trial Pipeline Insights | DelveInsight New York, USA, June 29, 2022 (GLOBE NEWSWIRE) -- Chronic Obstructive Pulmonary Disease Clinical Trial Pipeline Insights | DelveInsight The rising incidence of COPD and the exacerbations...